PEAK6’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$187M Buy
735,000
+300,600
+69% +$70.1M 0.38% 51
2026
Q1
$106M Buy
434,400
+58,000
+15% +$13.5M 0.25% 70
2025
Q4
$77.9M Buy
376,400
+110,900
+42% +$21.9M 0.14% 120
2025
Q3
$49.2M Buy
265,500
+198,800
+298% +$34.1M 0.07% 209
2025
Q2
$10.2M Sell
66,700
-690,200
-91% -$106M 0.02% 625
2025
Q1
$126M Buy
+756,900
New +$118M 0.28% 71

Other funds holding JNJ

PEAK6's JNJ Position: Q2 2026 in Review

PEAK6 sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 18,566 shares — an estimated $4.33M sold.

PEAK6 first reported a position in JNJ in Q1 2026 and held it in 1 quarter. The position peaked at $4.54M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • PEAK6 reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • PEAK6 sold 18,566 Johnson & Johnson shares in Q2 2026, an estimated $4.33M.
  • PEAK6 first reported a position in Johnson & Johnson in Q1 2026 and held it in 1 quarter.
  • PEAK6's Johnson & Johnson position peaked at $4.54M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.